3Shankar M,Lee CA,Sabin CA,et al.von Willebrand disease in women with menorrhagia:a systematic review.B JOG,2004,111:734-740.
4Marret H,Fauconnier A,Chabbert-Buffet N,et al.Clinical practice guidelines on menorrhagia:management of abnormal uterine bleeding before menopause.Eur J Obstet Gyneeol Reprod Biol,2010,152:133-137.
5Philipp CS,Faiz A,Dowling N,et al.Age and the prevalence of bleeding disorders in women with menorrhagia.Obstet Gynecol,2005,105:61-66.
6Hurskainen R,Teperi J,Rissanen P,et al.Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia:a randomised trial.Lancet,2001,357:273-277.
7Bhatia K,Doonan Y,Giannakou A,et al.A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium.BJOG,2008,115:1214-1224.
8Abbott JA,Garry R.The surgical management of menorrhagia.Hum Reprod Update,2002,8:68-78.
9Apgar BS,Kaufman AH,George-Nwogu U,et al.Treatment of menorrhagia.Am Fam Physician,2007,75:1813-1819.
10Ghazizadeh S,Bakhtiari F,Rahmanpour H,et al.A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia.Int J Womens Health,2011,3:207-211.
